The contribution of cohort studies to prescribing research

Journal of Clinical Pharmacy and Therapeutics

Volumn 27, Issue 2, 2002, Pages 151-156

  Simpson, J A ^a,b   Hannaford, P C ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Cohort studies; Prescribing research

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; ORAL CONTRACEPTIVE AGENT;

ACCURACY; ARTICLE; CLINICAL RESEARCH; CLINICAL STUDY; COHORT ANALYSIS; DECISION MAKING; ETHICS; EXPOSURE; HEALTH CARE; HUMAN; INCIDENCE; INDUCED ABORTION; MEDICAL DECISION MAKING; MORBIDITY; OBSERVATION; OUTCOMES RESEARCH; PRESCRIPTION; RANDOMIZATION; RISK ASSESSMENT; RISK FACTOR; SUICIDE;

COHORT STUDIES; CONTRACEPTIVES, ORAL; DRUG THERAPY; EVIDENCE-BASED MEDICINE; HUMANS; PATIENT SELECTION; PRESCRIPTIONS, DRUG; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 0036253794     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2002.00399.x     Document Type: Article

References (21)

1. Mortality among oral contraceptive users
2. Further analyses of mortality in oral contraceptive users
3. Cardiovascular disease and steroid hormone contraception: Report of a WHO scientific group
4. The Royal College of General Practitioners' Oral Contraception Study: Some recent observations
5. Effect on hypertension and benign breast disease of progestogen component in combined oral contraceptives
6. Progestogens and arterial disease - Evidence from Royal College of General Practitioners' study
7. Oral contraceptive use and malignancies of the genital tract. Results from the Royal College of General Practitioners' Oral Contraception Study
8. The risk of serious illness among oral contraceptive users: Evidence from the RCGP's oral contraceptive study
9. Mortality associated with oral contraceptive use: 25 Year follow up of cohort of 46 000 women from the Royal College of General Practitioners' oral contraception study
10. Cardiovascular sequelae of toxaemia of pregnancy
11. Prevalence and characteristics associated with use of hormone replacement therapy in Britain
12. Use of calcium channel blockers and risk of suicide: Ecological findings confirmed in population based cohort study
13. Postmarketing surveillance of the safety of cimetidine: 10-Year mortality report
14. Postmarketing surveillance study of a non-chlorofluorocarbon inhaler according to the safety assessment of marketed medicines guidelines
15. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: Cohort study
16. Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women
17. Induced abortion operations and their early sequelae
18. The effect of induced abortion on subsequent fertility
19. The effect of induced abortion on subsequent pregnancy outcome
20. Termination of pregnancy and psychiatric morbidity